Cyril Amarchand Mangaldas Advises Enzene Biosciences On Acquisition Of Minority Stake By Eight Roads
Cyril Amarchand Mangaldas advised Enzene Biosciences Limited (Enzene Biosciences) on acquisition of 8% minority stake in Enzene Biosciences (a subsidiary of Alkem Laboratories Limited) by Eight Roads Ventures and F-Prime Capital, for a total consideration of INR 161 crores (approx.)
The General Corporate Law Practices of Cyril Amarchand Mangaldas acted as the legal counsel for Enzene Biosciences on the transaction. The transaction team was led by Nagavalli G, Partner; with support from Ayushi Mishra, Senior Associate.
As a part of the Transaction, Eight Roads Ventures and F-Prime Capital acquired a minority stake in Enzene Biosciences through two separate non- resident funds, by subscribing to equity and preference shares of Enzene Biosciences.
The Transaction was signed on December 23, 2022.